Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Testing. This report contains market size and forecasts of Prostate Cancer Testing in global, including the following market information:
Global Prostate Cancer Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Testing market was valued at US$ 13820 million in 2022 and is projected to reach US$ 22650 million by 2029, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
We surveyed the Prostate Cancer Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Testing Market Segment Percentages, by Type, 2022 (%)
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others
Global Prostate Cancer Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Testing Market Segment Percentages, by Application, 2022 (%)
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
Global Prostate Cancer Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Testing, market overview.
Chapter 2: Global Prostate Cancer Testing market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Testing Overall Market Size
2.1 Global Prostate Cancer Testing Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Testing Players in Global Market
3.2 Top Global Prostate Cancer Testing Companies Ranked by Revenue
3.3 Global Prostate Cancer Testing Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Testing Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Testing Market Size Markets, 2022 & 2029
4.1.2 PSA Tests
4.1.3 CTC Tests
4.1.4 Immunohistochemistry
4.1.5 PCA3 Tests
4.1.6 Others
4.2 By Type - Global Prostate Cancer Testing Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Testing Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Testing Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Testing Market Size, 2022 & 2029
5.1.2 Hospital Associated Labs
5.1.3 Independent Diagnostic Laboratories
5.1.4 Cancer Research Institutes
5.1.5 Others
5.2 By Application - Global Prostate Cancer Testing Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Testing Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Testing Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Testing Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Testing Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Testing Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Testing Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Testing Revenue, 2018-2029
6.3.2 US Prostate Cancer Testing Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Testing Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Testing Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Testing Market Size, 2018-2029
6.4.3 France Prostate Cancer Testing Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Testing Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Testing Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Testing Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Testing Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Testing Revenue, 2018-2029
6.5.2 China Prostate Cancer Testing Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Testing Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Testing Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Testing Market Size, 2018-2029
6.5.6 India Prostate Cancer Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Testing Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Testing Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Testing Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Testing Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Testing Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Testing Market Size, 2018-2029
7 Prostate Cancer Testing Companies Profiles
7.1 Genomic Health
7.1.1 Genomic Health Company Summary
7.1.2 Genomic Health Business Overview
7.1.3 Genomic Health Prostate Cancer Testing Major Product Offerings
7.1.4 Genomic Health Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.1.5 Genomic Health Key News & Latest Developments
7.2 OPKO
7.2.1 OPKO Company Summary
7.2.2 OPKO Business Overview
7.2.3 OPKO Prostate Cancer Testing Major Product Offerings
7.2.4 OPKO Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.2.5 OPKO Key News & Latest Developments
7.3 Siemens Healthcare
7.3.1 Siemens Healthcare Company Summary
7.3.2 Siemens Healthcare Business Overview
7.3.3 Siemens Healthcare Prostate Cancer Testing Major Product Offerings
7.3.4 Siemens Healthcare Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.3.5 Siemens Healthcare Key News & Latest Developments
7.4 DiaSorin
7.4.1 DiaSorin Company Summary
7.4.2 DiaSorin Business Overview
7.4.3 DiaSorin Prostate Cancer Testing Major Product Offerings
7.4.4 DiaSorin Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.4.5 DiaSorin Key News & Latest Developments
7.5 bioMeriux
7.5.1 bioMeriux Company Summary
7.5.2 bioMeriux Business Overview
7.5.3 bioMeriux Prostate Cancer Testing Major Product Offerings
7.5.4 bioMeriux Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.5.5 bioMeriux Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Prostate Cancer Testing Major Product Offerings
7.6.4 Roche Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 MDx Health
7.7.1 MDx Health Company Summary
7.7.2 MDx Health Business Overview
7.7.3 MDx Health Prostate Cancer Testing Major Product Offerings
7.7.4 MDx Health Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.7.5 MDx Health Key News & Latest Developments
7.8 Beckman Coulter
7.8.1 Beckman Coulter Company Summary
7.8.2 Beckman Coulter Business Overview
7.8.3 Beckman Coulter Prostate Cancer Testing Major Product Offerings
7.8.4 Beckman Coulter Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.8.5 Beckman Coulter Key News & Latest Developments
7.9 Myriad Genetics
7.9.1 Myriad Genetics Company Summary
7.9.2 Myriad Genetics Business Overview
7.9.3 Myriad Genetics Prostate Cancer Testing Major Product Offerings
7.9.4 Myriad Genetics Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.9.5 Myriad Genetics Key News & Latest Developments
7.10 Ambry Genetics
7.10.1 Ambry Genetics Company Summary
7.10.2 Ambry Genetics Business Overview
7.10.3 Ambry Genetics Prostate Cancer Testing Major Product Offerings
7.10.4 Ambry Genetics Prostate Cancer Testing Revenue in Global Market (2018-2023)
7.10.5 Ambry Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Testing Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Testing Market Drivers in Global Market
Table 3. Prostate Cancer Testing Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Testing in Global Market
Table 5. Top Prostate Cancer Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Testing Product Type
Table 9. List of Global Tier 1 Prostate Cancer Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Testing Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Prostate Cancer Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Testing Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Prostate Cancer Testing Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Prostate Cancer Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Testing Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Prostate Cancer Testing Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Prostate Cancer Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Testing Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Prostate Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Testing Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Prostate Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Testing Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Prostate Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Testing Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Prostate Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Testing Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Prostate Cancer Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Testing Revenue, (US$, Mn), 2024-2029
Table 30. Genomic Health Company Summary
Table 31. Genomic Health Prostate Cancer Testing Product Offerings
Table 32. Genomic Health Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Genomic Health Key News & Latest Developments
Table 34. OPKO Company Summary
Table 35. OPKO Prostate Cancer Testing Product Offerings
Table 36. OPKO Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 37. OPKO Key News & Latest Developments
Table 38. Siemens Healthcare Company Summary
Table 39. Siemens Healthcare Prostate Cancer Testing Product Offerings
Table 40. Siemens Healthcare Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Siemens Healthcare Key News & Latest Developments
Table 42. DiaSorin Company Summary
Table 43. DiaSorin Prostate Cancer Testing Product Offerings
Table 44. DiaSorin Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 45. DiaSorin Key News & Latest Developments
Table 46. bioMeriux Company Summary
Table 47. bioMeriux Prostate Cancer Testing Product Offerings
Table 48. bioMeriux Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 49. bioMeriux Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Prostate Cancer Testing Product Offerings
Table 52. Roche Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. MDx Health Company Summary
Table 55. MDx Health Prostate Cancer Testing Product Offerings
Table 56. MDx Health Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 57. MDx Health Key News & Latest Developments
Table 58. Beckman Coulter Company Summary
Table 59. Beckman Coulter Prostate Cancer Testing Product Offerings
Table 60. Beckman Coulter Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Beckman Coulter Key News & Latest Developments
Table 62. Myriad Genetics Company Summary
Table 63. Myriad Genetics Prostate Cancer Testing Product Offerings
Table 64. Myriad Genetics Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 65. Myriad Genetics Key News & Latest Developments
Table 66. Ambry Genetics Company Summary
Table 67. Ambry Genetics Prostate Cancer Testing Product Offerings
Table 68. Ambry Genetics Prostate Cancer Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Ambry Genetics Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Testing Segment by Type in 2022
Figure 2. Prostate Cancer Testing Segment by Application in 2022
Figure 3. Global Prostate Cancer Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Testing Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prostate Cancer Testing Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Testing Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 9. By Application - Global Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 10. By Type - Global Prostate Cancer Testing Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 12. By Application - Global Prostate Cancer Testing Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 14. By Region - Global Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 15. By Country - North America Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 16. US Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 20. Germany Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 21. France Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 28. China Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 32. India Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 34. Brazil Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Prostate Cancer Testing Revenue Market Share, 2018-2029
Figure 37. Turkey Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Prostate Cancer Testing Revenue, (US$, Mn), 2018-2029
Figure 41. Genomic Health Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. OPKO Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Siemens Healthcare Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. DiaSorin Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. bioMeriux Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roche Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. MDx Health Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Beckman Coulter Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Myriad Genetics Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ambry Genetics Prostate Cancer Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
